New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 3, 2014
11:20 EDTVNDAVanda shares attractive amid negative sentiment, says Piper Jaffray
Piper Jaffray believes the negative sentiment surrounding shares of Vanda Pharmaceuticals presents an excellent entry point into the name. Piper says Vanda has yet to ramp its physician education efforts regarding Hetlioz and that the dug has the potential to be a multi-hundred million dollar product. The firm reiterates an Overweight rating on Vanda with a $21 price target.
News For VNDA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 6, 2014
14:44 EDTVNDAVanda Pharmaceuticals volatility increases on wide price movement
Vanda Pharmaceuticals October call option implied volatility is at 99, November is at 108, December is at 98, January is at 97; compered to its 26-week average of 88 according to Track Data, suggesting large price movement.
10:14 EDTVNDAHigh option volume stocks
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use